CTLA4 and cancer: ICIs target immune checkpoint proteins like cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), programmed cell death-1 (PD-1), and programmed cell death-ligand 1 (PD-L1), which cancer cells exploit to evade immune detection.